Skip to main content

Peer Review reports

From: Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review

Original Submission
13 Nov 2018 Submitted Original manuscript
27 Dec 2018 Author responded Author comments - Takuma Imakita
15 Dec 2018 Reviewed Reviewer Report - Frederick Hausheer
16 Dec 2018 Reviewed Reviewer Report - Henry Park
17 Dec 2018 Reviewed Reviewer Report - Andrea Martoni
Resubmission - Version 2
27 Dec 2018 Submitted Manuscript version 2
10 Jan 2019 Author responded Author comments - Takuma Imakita
Resubmission - Version 3
10 Jan 2019 Submitted Manuscript version 3
Publishing
18 Jan 2019 Editorially accepted
25 Jan 2019 Article published 10.1186/s12885-019-5309-x

You can find further information about peer review here.

Back to article page
\